Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rapid response research to emerging infectious diseases: lessons from SARS

Identifieur interne : 001551 ( Pmc/Checkpoint ); précédent : 001550; suivant : 001552

Rapid response research to emerging infectious diseases: lessons from SARS

Auteurs : B. Brett Finlay ; Raymond H. See ; Robert C. Brunham

Source :

RBID : PMC:7097457

Abstract

New and emerging infectious diseases continue to plague the world, and there is significant concern that recombinant infectious agents can be used as bioterrorism threats. Microbiologists are increasingly being asked to apply their scientific knowledge to respond to these threats. The recent pandemic caused by the severe acute respiratory syndrome (SARS) coronavirus illustrated not only how a newly evolved pathogen can rapidly spread throughout the world but also how the global community can unite to identify the causative agent and control its spread. Rapid response research mechanisms, such as those used by the SARS Accelerated Vaccine Initiative (SAVI), have shown that the application of emergency management techniques, together with rapid response research, can be highly effective when applied appropriately to new infectious diseases.


Url:
DOI: 10.1038/nrmicro930
PubMed: 15197395
PubMed Central: 7097457


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7097457

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rapid response research to emerging infectious diseases: lessons from SARS</title>
<author>
<name sortKey="Finlay, B Brett" sort="Finlay, B Brett" uniqKey="Finlay B" first="B. Brett" last="Finlay">B. Brett Finlay</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Biotechnology Laboratory and Departments of Biochemistry and Molecular Biology and Microbiology and Immunology,</institution>
<institution>University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</nlm:aff>
<wicri:noCountry code="subfield">V6T 1Z3 British Columbia Canada</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="See, Raymond H" sort="See, Raymond H" uniqKey="See R" first="Raymond H." last="See">Raymond H. See</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Department of Medicine, Division of Infectious Diseases,</institution>
<institution>BC CDC, University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</nlm:aff>
<wicri:noCountry code="subfield">V6T 1Z3 British Columbia Canada</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C." last="Brunham">Robert C. Brunham</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Department of Medicine, Division of Infectious Diseases,</institution>
<institution>BC CDC, University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</nlm:aff>
<wicri:noCountry code="subfield">V6T 1Z3 British Columbia Canada</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">15197395</idno>
<idno type="pmc">7097457</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097457</idno>
<idno type="RBID">PMC:7097457</idno>
<idno type="doi">10.1038/nrmicro930</idno>
<date when="2004">2004</date>
<idno type="wicri:Area/Pmc/Corpus">000562</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000562</idno>
<idno type="wicri:Area/Pmc/Curation">000562</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000562</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001551</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001551</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Rapid response research to emerging infectious diseases: lessons from SARS</title>
<author>
<name sortKey="Finlay, B Brett" sort="Finlay, B Brett" uniqKey="Finlay B" first="B. Brett" last="Finlay">B. Brett Finlay</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Biotechnology Laboratory and Departments of Biochemistry and Molecular Biology and Microbiology and Immunology,</institution>
<institution>University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</nlm:aff>
<wicri:noCountry code="subfield">V6T 1Z3 British Columbia Canada</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="See, Raymond H" sort="See, Raymond H" uniqKey="See R" first="Raymond H." last="See">Raymond H. See</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Department of Medicine, Division of Infectious Diseases,</institution>
<institution>BC CDC, University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</nlm:aff>
<wicri:noCountry code="subfield">V6T 1Z3 British Columbia Canada</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C." last="Brunham">Robert C. Brunham</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Department of Medicine, Division of Infectious Diseases,</institution>
<institution>BC CDC, University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</nlm:aff>
<wicri:noCountry code="subfield">V6T 1Z3 British Columbia Canada</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Nature Reviews. Microbiology</title>
<idno type="ISSN">1740-1526</idno>
<idno type="eISSN">1740-1534</idno>
<imprint>
<date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="Par4">New and emerging infectious diseases continue to plague the world, and there is significant concern that recombinant infectious agents can be used as bioterrorism threats. Microbiologists are increasingly being asked to apply their scientific knowledge to respond to these threats. The recent pandemic caused by the severe acute respiratory syndrome (SARS) coronavirus illustrated not only how a newly evolved pathogen can rapidly spread throughout the world but also how the global community can unite to identify the causative agent and control its spread. Rapid response research mechanisms, such as those used by the SARS Accelerated Vaccine Initiative (SAVI), have shown that the application of emergency management techniques, together with rapid response research, can be highly effective when applied appropriately to new infectious diseases.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Kombe, Gc" uniqKey="Kombe G">GC Kombe</name>
</author>
<author>
<name sortKey="Darrow, Dm" uniqKey="Darrow D">DM Darrow</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Feldmann, H" uniqKey="Feldmann H">H Feldmann</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Poutanen, Sm" uniqKey="Poutanen S">SM Poutanen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Marra, Ma" uniqKey="Marra M">MA Marra</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rota, Pa" uniqKey="Rota P">PA Rota</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ruan, Yj" uniqKey="Ruan Y">YJ Ruan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tan, Yj" uniqKey="Tan Y">YJ Tan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Liu, X" uniqKey="Liu X">X Liu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Woo, Pc" uniqKey="Woo P">PC Woo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ndifuna, A" uniqKey="Ndifuna A">A Ndifuna</name>
</author>
<author>
<name sortKey="Waters, Ak" uniqKey="Waters A">AK Waters</name>
</author>
<author>
<name sortKey="Zhou, M" uniqKey="Zhou M">M Zhou</name>
</author>
<author>
<name sortKey="Collisson, Ew" uniqKey="Collisson E">EW Collisson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cui, W" uniqKey="Cui W">W Cui</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lin, M" uniqKey="Lin M">M Lin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Olsen, Cw" uniqKey="Olsen C">CW Olsen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kenney, Rt" uniqKey="Kenney R">RT Kenney</name>
</author>
<author>
<name sortKey="Edelman, R" uniqKey="Edelman R">R Edelman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gurunathan, S" uniqKey="Gurunathan S">S Gurunathan</name>
</author>
<author>
<name sortKey="Klinman, Dm" uniqKey="Klinman D">DM Klinman</name>
</author>
<author>
<name sortKey="Seder, Ra" uniqKey="Seder R">RA Seder</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fouchier, Ra" uniqKey="Fouchier R">RA Fouchier</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kuiken, T" uniqKey="Kuiken T">T Kuiken</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Marshall, E" uniqKey="Marshall E">E Marshall</name>
</author>
<author>
<name sortKey="Enserink, M" uniqKey="Enserink M">M Enserink</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Martina, Be" uniqKey="Martina B">BE Martina</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Subbarao, K" uniqKey="Subbarao K">K Subbarao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gao, W" uniqKey="Gao W">W Gao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bisht, H" uniqKey="Bisht H">H Bisht</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yang, Zy" uniqKey="Yang Z">ZY Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Biddle, Ja" uniqKey="Biddle J">JA Biddle</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Allison, N" uniqKey="Allison N">N Allison</name>
</author>
<author>
<name sortKey="Tranter, Hs" uniqKey="Tranter H">HS Tranter</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Viret, Jf" uniqKey="Viret J">JF Viret</name>
</author>
<author>
<name sortKey="Gluck, R" uniqKey="Gluck R">R Gluck</name>
</author>
<author>
<name sortKey="Moser, C" uniqKey="Moser C">C Moser</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baston, N" uniqKey="Baston N">N Baston</name>
</author>
<author>
<name sortKey="Glass, S" uniqKey="Glass S">S Glass</name>
</author>
<author>
<name sortKey="Seiguer, E" uniqKey="Seiguer E">E Seiguer</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="La Montagne, Jr" uniqKey="La Montagne J">JR La Montagne</name>
</author>
<author>
<name sortKey="Simonsen, L" uniqKey="Simonsen L">L Simonsen</name>
</author>
<author>
<name sortKey="Taylor, Rj" uniqKey="Taylor R">RJ Taylor</name>
</author>
<author>
<name sortKey="Turnbull, J" uniqKey="Turnbull J">J Turnbull</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stadler, K" uniqKey="Stadler K">K Stadler</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nat Rev Microbiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Microbiol</journal-id>
<journal-title-group>
<journal-title>Nature Reviews. Microbiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1740-1526</issn>
<issn pub-type="epub">1740-1534</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">15197395</article-id>
<article-id pub-id-type="pmc">7097457</article-id>
<article-id pub-id-type="publisher-id">BFnrmicro930</article-id>
<article-id pub-id-type="doi">10.1038/nrmicro930</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rapid response research to emerging infectious diseases: lessons from SARS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Finlay</surname>
<given-names>B. Brett</given-names>
</name>
<address>
<email>bfinlay@interchange.ubc.ca</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<bio>
<p id="Par1">B. Brett Finlay is the Peter Wall and CIHR Distinguished Professor in the Biotechnology Laboratory at the University of British Columbia. He obtained a B.Sc. (Hons) and Ph.D. in Biochemistry at the University of Alberta. His postdoctoral studies were undertaken with Professor Stanley Falkow in the Department of Medical Microbiology and Immunology at Stanford University School of Medicine. His research interests include the interactions between pathogenic
<italic>Escherichia coli</italic>
and
<italic>Salmonella</italic>
spp. and host cells at a molecular level, as well as how these pathogens circumvent innate host responses. He has won several prestigious awards, including the E.W.R. Steacie Prize in 1999, the CSM Fisher Scientific Award, a CIHR Distinguished Investigator award and is a Fellow of the Royal Society of Canada.</p>
</bio>
</contrib>
<contrib contrib-type="author">
<name>
<surname>See</surname>
<given-names>Raymond H.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<bio>
<p id="Par2">Raymond See received his Ph.D. from the University of British Columbia Department of Experimental Pathology in 1992 where he studied the mechanism of action of staphylococcal toxic shock syndrome toxin-1 on human peripheral blood mononuclear cells. During his Ph.D. training, he received numerous awards for his research, including the Western Society for Investigation Student Award and the Canadian Society for Clinical Investigation Trainee Award. From 1993 to 1999 he did his postdoctoral training at Harvard Medical School of Pathology in Boston and was supported by a Medical Research Council (now CIHR) postdoctoral fellowship award. During the course of his graduate and postdoctoral training, he has published 22 papers in peer-reviewed journals. After his postdoctoral training, he joined Consensus Pharmaceuticals Inc. (Medford, Massachusetts, USA) as a senior scientist. In 2000, he returned to Vancouver as a project leader for Xenon Genetics Inc. There, he led a team responsible for biological assay development as well as small-molecule screening for two major drug targets related to lipid metabolism. He joined SAVI as the programme director of vaccine development in November 2003.</p>
</bio>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brunham</surname>
<given-names>Robert C.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<bio>
<p id="Par3">Robert C. Brunham is Director of the University of British Columbia Centre for Disease Control (UBC CDC) and Medical Director of the British Columbia Centre for Disease Control Society (BCCDC). He is a Professor in the Department of Medicine, Division of Infectious Diseases at the University of British Columbia. He obtained his M.D. from UBC in 1972 and completed training in Internal Medicine at McGill University in 1978. From 1978 to 1982, Professor Brunham was a Medical Research Council of Canada research fellow at the University of Washington, USA under the supervision of Dr King Holmes. From 1982 to 1999 he was at the University of Manitoba, Canada, where he was Professor and Chairman of the Department of Medical Microbiology and Infectious Diseases from 1988 to 1999. His research interests centre on the immunology, epidemiology and genomics of infectious diseases. He has published more than 200 articles and book chapters on various aspects of infectious diseases, with an emphasis on sexually transmitted diseases. Much of his work has dealt with the immunobiology and epidemiology of
<italic>Chlamydia trachomatis</italic>
with the goal of developing a vaccine. As Director of the UBC CDC, his recent work has dealt with emerging infectious diseases such as SARS.</p>
</bio>
</contrib>
<aff id="Aff1">
<label>1</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Biotechnology Laboratory and Departments of Biochemistry and Molecular Biology and Microbiology and Immunology,</institution>
<institution>University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</aff>
<aff id="Aff2">
<label>2</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.17091.3e</institution-id>
<institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id>
<institution>Department of Medicine, Division of Infectious Diseases,</institution>
<institution>BC CDC, University of British Columbia,</institution>
</institution-wrap>
Vancouver, V6T 1Z3 British Columbia Canada</aff>
</contrib-group>
<pub-date pub-type="ppub">
<year>2004</year>
</pub-date>
<volume>2</volume>
<issue>7</issue>
<fpage>602</fpage>
<lpage>607</lpage>
<permissions>
<copyright-statement>© Nature Publishing Group 2004</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par4">New and emerging infectious diseases continue to plague the world, and there is significant concern that recombinant infectious agents can be used as bioterrorism threats. Microbiologists are increasingly being asked to apply their scientific knowledge to respond to these threats. The recent pandemic caused by the severe acute respiratory syndrome (SARS) coronavirus illustrated not only how a newly evolved pathogen can rapidly spread throughout the world but also how the global community can unite to identify the causative agent and control its spread. Rapid response research mechanisms, such as those used by the SARS Accelerated Vaccine Initiative (SAVI), have shown that the application of emergency management techniques, together with rapid response research, can be highly effective when applied appropriately to new infectious diseases.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Nature Limited 2004</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</pmc>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C." last="Brunham">Robert C. Brunham</name>
<name sortKey="Finlay, B Brett" sort="Finlay, B Brett" uniqKey="Finlay B" first="B. Brett" last="Finlay">B. Brett Finlay</name>
<name sortKey="See, Raymond H" sort="See, Raymond H" uniqKey="See R" first="Raymond H." last="See">Raymond H. See</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001551 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 001551 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:7097457
   |texte=   Rapid response research to emerging infectious diseases: lessons from SARS
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i   -Sk "pubmed:15197395" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021